Insider trades › Johnson & Johnson · Johnson & Johnson company page
Johnson & Johnson insider trading
Transactions in JNJ stock reported by Johnson & Johnson executives, directors and large holders on SEC Form 4 over the last 120 days. Last update 2026-10-14.
$67.8Mopen-market sales (259,340 shares, 5 insiders)
$0open-market purchases (0 shares, 0 insiders)
9Form 4 filings
Insiders
Joaquin Duato CEO and Chairman of the Board, Director Sold $44.7M Timothy Schmid EVP, WW Chair, MedTech Sold $9.2M Vanessa Broadhurst EVP, Global Corp Affairs Sold $5.8M Elizabeth Forminard EVP, Chief Legal Officer Sold $4.1M Jennifer L Taubert EVP, WWC. Innovative Medicine Sold $4.0M
All transactions
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Option or RSU exercise | 11,070 | $131.94 | — | Form 4 ↗ |
| Sep 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Open-market sale | 11,070 | $274.74 | $3.0M | Form 4 ↗ |
| Sep 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Option or RSU exercise | 22,527 | $151.41 | — | Form 4 ↗ |
| Sep 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Open-market sale | 22,527 | $274.74 | $6.2M | Form 4 ↗ |
| Aug 17, 2026 | Jennifer L Taubert EVP, WWC. Innovative Medicine | Option or RSU exercise | 15,000 | $115.67 | — | Form 4 ↗ |
| Aug 17, 2026 | Jennifer L Taubert EVP, WWC. Innovative Medicine | Open-market sale | 15,000 | $263.36 | $4.0M | Form 4 ↗ |
| Aug 13, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Option or RSU exercise | 123,291 | $115.67 | — | Form 4 ↗ |
| Aug 13, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Open-market sale | 20,976 | $262.00 | $5.5M | Form 4 ↗ |
| Aug 13, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Open-market sale | 102,315 | $261.00 | $26.7M | Form 4 ↗ |
| Aug 6, 2026 | Elizabeth Forminard EVP, Chief Legal Officer | Option or RSU exercise | 9,344 | $131.94 | — | Form 4 ↗ |
| Aug 6, 2026 | Elizabeth Forminard EVP, Chief Legal Officer | Open-market sale | 9,344 | $257.75 | $2.4M | Form 4 ↗ |
| Aug 6, 2026 | Elizabeth Forminard EVP, Chief Legal Officer | Open-market sale | 6,574 | $255.93 | $1.7M | Form 4 ↗ |
| Aug 5, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Open-market sale | 41,957 | $258.06 | $10.8M | Form 4 ↗ |
| Aug 5, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Open-market sale | 6,523 | $258.74 | $1.7M | Form 4 ↗ |
| Jul 20, 2026 | Vanessa Broadhurst EVP, Global Corp Affairs | Option or RSU exercise | 11,129 | $129.51 | — | Form 4 ↗ |
| Jul 20, 2026 | Vanessa Broadhurst EVP, Global Corp Affairs | Option or RSU exercise | 11,925 | $131.94 | — | Form 4 ↗ |
| Jul 20, 2026 | Vanessa Broadhurst EVP, Global Corp Affairs | Open-market sale | 23,054 | $251.27 | $5.8M | Form 4 ↗ |
Source: SEC EDGAR, Johnson & Johnson Form 4 filings. Values are shares × reported price for open-market trades. Insider trades are reported facts, not recommendations. Not investment advice. See the tracker for how to read the codes.